Top Software Companies in Belfast (176)

Strong Market Position & Advantage: Adoption among major insurance brokers is described as deep, with 8 of the 10 largest U.S. brokers and many top-ranked agencies using an Applied system in 2025. Recognition such as Applied Epic’s inclusion in G2’s 2026 Top 100 and a large installed base reinforce a leading position in agency/broker management software.

Innovation-Driven Growth: Product expansion through AI-focused acquisitions such as Planck (2024) and Cytora (2025) adds risk digitization and automation capabilities. New offerings like Applied Recon, rapid growth in Applied Pay usage, and a “submissionless” experience with Travelers indicate active innovation driving usage.

Investor Backing & Capital Strength: Long-term backing from Hellman & Friedman, alongside Stone Point Capital, JMI Equity, and CapitalG, supports ongoing investment capacity and M&A. Multi-year ownership since 2014 aligns with continued acquisitions and product expansion.

Strong Revenue Growth: Historical metrics indicate rapid scaling, with gross revenue rising from under $300M in 2018 to roughly $900M in 2020. Platform volume also surpassed $2B in 2019 alongside very strong year-over-year growth at that time.

Investor Backing & Capital Strength: The company secured major financings, including $300M rounds in 2019 and 2021 at valuations of about $1.9B and $2.9B, bringing total funding above $750M. These rounds signal strong investor confidence during periods when the business was scaling across customers and service categories.

Product Line Growth: Offerings expanded beyond a labor marketplace into an energy-specific source-to-pay and vendor management platform, with additions such as bid management, technology licensing, and an engineering acquisition. Recent moves like launching vendor management, licensing Shell’s U‑lateral technology, and acquiring Codeco‑Vanoco Engineering suggest ongoing product and capability expansion.

Strong Market Position & Advantage: Adoption spans 1,300+ biotechnology organizations with usage reported across more than half of the top 50 biopharma companies, signaling durable positioning in life‑sciences R&D software. Multiple sources characterize the platform as a leading life‑sciences R&D cloud used by both startups and major enterprises.

Product Line Growth: The company continues to launch and expand major offerings, including Benchling AI, antibody‑discovery capabilities, automation/analysis tools, and extensions into new scientific workflows such as small‑molecule chemistry. Acquisitions like PipeBio further broaden capability depth in biologics and related R&D domains.

Innovation-Driven Growth: AI is a clear growth vector, with reports that 500 biotech companies used Benchling AI in its first year and the product subsequently reached general availability. Team acquisitions (e.g., ReSync Bio and Sphinx Bio) and partnerships (e.g., with Anthropic) underscore a deliberate push to embed advanced models into scientific workflows.

Profitability: Adjusted EBITDA and margins expanded, with Q2 2026 EBITDA up 30% year over year and margin improving to 37%, alongside higher net income. This pattern indicates operating leverage as earnings outpace the top line.

Strong Revenue Growth: Revenue rose 7% in 2025 and accelerated to 11% year over year in Q2 2026, with multiple sequential quarters showing improving trends. The recent trajectory points to faster growth rather than a flat profile.

Healthy Cash Flow: Free cash flow is guided to grow at more than 30% for 2026 and was later raised to the high-40% range, while Q2 2026 generated $57.4M in operating cash. Debt reduction in 1H 2026, including repayment of $205M in convertibles, further supports balance-sheet strength.

Product Line Growth: Product scope has widened beyond core clearing/custody, with launches such as Apex Ascend (real-time, cloud-native infrastructure), Apex Alts, and new capabilities like AI tools, prediction markets, and direct indexing, plus acquisitions including FinTron and AdvisorArch. These additions indicate a broader platform designed to serve more wealth-tech workflows and asset types.

Strategic Partnerships: Recent announcements highlight collaborations with major platforms and institutions, including Cash App Investing selecting Apex as a strategic clearing platform, Gemini choosing Apex for U.S. stock-trading custody/clearing, and integrations/alliances with Plaid, Google Cloud, and State Street. These relationships point to expanding distribution and external validation of the offering.

Strong Market Position & Advantage: Operating scale is substantial, with company-reported figures of hundreds of billions in assets under custody, tens of millions of accounts, and hundreds of millions of annual trades, alongside support for 200+ platforms. High-profile platform selections reinforce a durable position in digital investing infrastructure.

Strong Revenue Growth: Annual recurring revenue is described as rising sharply over recent periods with continued uplift into the following year. These signals point to a scaling recurring-revenue model rather than one-off sales.

Market Expansion: Hundreds of new customer logos were added across successive years, with net customer growth and significant increases in cloud usage across regions such as Asia and ANZ. This reflects expansion beyond North America and deeper penetration within the installed base.

Innovation-Driven Growth: Rapid cloud migration and the rollout of AI capabilities (e.g., Ask iManage, AI Enrichment, Insight+) are portrayed as key adoption catalysts. These innovations appear to be driving multi-solution uptake and greater platform stickiness among enterprises.

Profitability: Bottom-line performance is strengthening, with consistent earnings beats, improved non-GAAP operating income, and durable free cash flow. Management is prioritizing margin expansion alongside operational efficiency.

Healthy Cash Flow: The business is generating solid free cash flow, with recent periods and guidance pointing to sustained cash generation. This supports stability even as revenue growth moderates.

Strong Market Position & Advantage: The company is repeatedly recognized as a leader in MDR, exposure management, and SIEM by major analyst programs. A large global customer base underscores established scale in its core markets.

Strong Revenue Growth: Revenue is reported to have risen to about £1.161bn in FY25 from £1.008bn in FY24, alongside continued double-digit organic growth—signals of sustained top-line momentum.

Strong Market Position & Advantage: The company is positioned as one of the largest UK-headquartered business management software providers, serving 160,000+ organizations across multiple regions and maintaining notable mid-market and vertical-suite penetration.

Innovation-Driven Growth: The rollout of the AI-enabled Access Evo platform and the launch of 60+ new AI-enabled products in FY25 indicate an active product innovation engine intended to deepen adoption and drive further growth.

Strong Revenue Growth: Sales increased in 2025 versus 2024, with early 2026 also showing higher sales and management guiding to further organic growth in 2026.

Profitability: Adjusted EBIT rose and margins improved in 2025, indicating strengthening operating performance alongside growth.

Resilient & Sustainable Growth: Record order intake and an order book above €53 billion provide multi‑year visibility, and a book‑to‑bill above 1 with reaffirmed 2026 targets supports continued expansion.